Founded in Massachusetts, Akeso Biomedical is a biotechnology company dedicated to developing antibiotic-free feed additives aimed at treating bacterial infections. The company's core mission is to provide innovative solutions that enhance animal health and reduce the reliance on traditional antibiotics, thereby addressing the growing concern of antibiotic resistance. Akeso Biomedical's products are primarily targeted at the agricultural sector, focusing on improving the health and productivity of livestock through advanced, sustainable feed additives.
Akeso Biomedical is affiliated with VIC Technology Venture Development, a notable investor and supporter in the biotech space. The company has achieved significant milestones in its field, including the development of proprietary feed additives that have shown promising results in reducing bacterial infections without the use of antibiotics. By offering effective alternatives to conventional treatments, Akeso Biomedical is making a substantial impact on animal health management and contributing to global efforts to combat antibiotic resistance.